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Abstract 
Pattern of dyslipoproteinemia was studied ,over a period of 3-1/2 years in 487(394 males, 93 females)
cases aged 4 to above 70 years. Type IV hyperlipoproteinemia was most prevalent (36%) followed by
type V (15%) (JPMA 44:165,1994).
Introduction 
Lipid abnormalities are frequent both in healthy school going children and adults in Pakistan1,2. Studies
in neonates and their mothers indicate that diet may be an important aetiological factor for hyper
cholesterolaemia in children3. A substantial number of Pakistanis get their first heart attack in the
fourth decade of life3 and hypertriglyceridaemia and low LDL has been reported in hypertensive
subjects4. Lipoprotein phenoytyping is useful in classifying lipid abnormalities and helps in assessing
the probable cause of the lipid disorders5. The present study was undertaken to see the pattern of
dyslipoproteinemia in a selected group of hyperlipidemic patients.
Patients and Methods 
All the patients referred to clinical laboratory at The Aga Khan University Medical Centre, for
lipoprotein electrophoresis between October, 1989 to March, 1993 were included. Patients were fasting
for 12 hours. Five ml. blood was collected in plain tube and serum stored at 4°C. The paragon
lipoprotein electrophoresis (LEP) kit P/N 855910 (Beck men Instruments Inc/Diagnostic System
Group) was used for electrophoretic separation of lipoproteins in human serum. Phenotypes were
described according to Fredrickson’s classification6.
Results 
Patients were divided into different age groups from 0 to greater than 70 years. Phenotypes were
identified and mentioned against each age group. Total number along with specific type of
hyperlipidemia in individual age groups were studied and their percentages were calculated (Tables I,II
and III).

Maximum number of patients (101) were in the age. group of 40 to 44 years which constitute 20.7% of
total population studied. Type IV hyperlipidemia, defined as broad pre-beta band with moderate to
markedly increased VLDL in LEP was most prevalent (35.9%) in all age groups. This included 2 of the
6 patients between the ages of 0 to 4 years. Type I hyperlipidemia, defined by the presence of an
intense band at application with moderate to markedly increased chylomicrones in the LEP, is most
prevalent (48.6%) in age group of 35 to 44 years. Pure hypercholesteremia type IIa, defined as beta
lipoproteins in the LEP and grossly elevated with normal triglycerides and chylomicrones, mixed
variety type IIb, defined as increased beta and pre-beta lipoproteins in the LEP and type III (defined as
intermediate density lipoprotein fraction appearing between beta and pre-beta band cholesterol and
triglycerides slightly or grossly elevated in the LEP) were found in very few patients constituting 1 to
1.2% of the total population respectively.
Discussion 
The present study done on a very selected group, does not represent the entire population of Karachi.
However, it provides an opportunity to see the prevalence of different patterns of dyslipoproteinemia in
this population. Lipoprotein phenotyping is useful in classifying lipid abnormalities and in assessing
probable cause of underlying disorders. However, a given type may be due to the presence of various
genetic abnormalities3. The result of this study indicate high prevalence of hyper triglyceridemia in
contrast to the previous study which showed high incidence of hypercholesterolemia7. However,
previous studies were done on a sample of healthy population selected at random whereas in this study
all the patients were referral cases suspected to have hyperlipidemia. Further workup is, hence, strongly
emphasized. High incidence of moderate to severe hypertriglyceridemia (type IV, V and I) is alarming
because of its association with atherosclerosis, constituting 6% of all the incidence with myocardial
infarction8. Evidence support the view that hyper triglyceridemia is more commonly associated with
obesity, uncontrolled diabetes meilitus, access of alcohol ingestion, renal failure, SLE, lipodystrophy,
glycogen storage disease and use of various medications like beta-blockers and oral contraceptives4.
The result of this study demands a more comprehensive prospective study to evaluate the involvement
of secondary factors in development of dyslipoproteinemia and molecular defects (determined by using
latest predieator, plasma apolipoproteins, forming the genetic basis of lipid disorders in our population.
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